Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 2, 2018
Reporting Period: Single event date (October 2, 2018)
This filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors or analysts on October 2, 2018, and subsequently.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing to distribute an investor presentation rather than a financial statement report.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The primary event is the distribution of forward-looking or strategic information contained in the attached presentation.
Guidance, Outlook, and Risks
- Management Commentary: The company is providing an investor presentation for use in investor relations meetings.
- Legal Status of Information: The information furnished in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Incorporation by Reference: The information will not be incorporated by reference into any other filings under the Securities Act or Exchange Act unless expressly referenced.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated October 2018) for specific financial data, guidance, and strategic updates, as these are not included in the 8-K text itself.
- Verify the date and content of the investor presentation to ensure it aligns with the October 2, 2018, reporting date.
- Note that the information in this filing is not legally "filed" for liability purposes under Section 18 of the Exchange Act.